A Atid, Nitrendipin CEP of the European Pharmacopoeia monograph is often referred to as a Atid, Nitrendipin Certificate of Suitability (COS). The purpose of a Atid, Nitrendipin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Atid, Nitrendipin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Atid, Nitrendipin to their clients by showing that a Atid, Nitrendipin CEP has been issued for it. The manufacturer submits a Atid, Nitrendipin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Atid, Nitrendipin CEP holder for the record. Additionally, the data presented in the Atid, Nitrendipin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Atid, Nitrendipin DMF.
A Atid, Nitrendipin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Atid, Nitrendipin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Atid, Nitrendipin suppliers with CEP (COS) on PharmaCompass.